Posttherapeutic skeletal muscle mass recovery predicts favorable prognosis in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy
Urologic Oncology: Seminars and Original Investigations Oct 28, 2017
Fukushima H, et al. - The prognostic role of post-therapeutic SMM recovery (PSR) among patients with advanced urothelial carcinoma (aUC) receiving first-line platinum-based chemotherapy was studied. It was shown that PSR was a novel prognostic factor in patients with aUC receiving first-line platinum-based chemotherapy.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
